ScholarIQanswers from OpenAlex & ORCID
Anthony Keech
ResearcherPublications, citations & collaboration network
Anthony Keech is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Anthony Keech have?
ScholarIQindexed works
Anthony Keech has 534 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Anthony Keech have?
ScholarIQcitation count
Anthony Keech has 32,986 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Anthony Keech?
ScholarIQh-index
Anthony Keech has an h-index of 85 in OpenAlex.
What is the i10-index of Anthony Keech?
ScholarIQi10-index
Anthony Keech has an i10-index of 233 in OpenAlex.
What is the ORCID of Anthony Keech?
ScholarIQorcid
The ORCID for Anthony Keech is on the source record.
What is the OpenAlex record for Anthony Keech?
ScholarIQopenalex
The OpenAlex for Anthony Keech is on the source record.
What are the most-cited papers on Anthony Keech?
ScholarIQmost cited works
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine, Robert P. Giugliano, Anthony Keech, Narimon Honarpour, Stephen D. Wiviott, Sabina A. Murphy, Julia Kuder, Huei Wang, Thomas Liu, Scott M. Wasserman, Peter Sever, Terje R. Pedersen
Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials
Jane Armitage, Colin Baigent, Elizabeth H Barnes, D. J. Betteridge, Lisa Blackwell, Michael A. Blazing, Louise Bowman, Eugene Braunwald, Robert Byington, Christopher P. Cannon, Michael Clearfield, Helen M. Colhoun, Rory Collins, Björn Dahlöf, Kelly Davies, Barry R. Davis, James A. de Lemos, John R. Downs, Paul N. Durrington, Jonathan Emberson, Bengt Fellström, Marcus Flather, Ian Ford, Maria Grazia Franzosi, Jordan Fulcher, John A. Fuller, Curt D. Furberg, David Gordon, Shinya Goto, Antonio M. Gotto, Heather Halls, Charlie Harper, C. Hawkins, William G. Herrington, G. A. Hitman, Hallvard Holdaas, Lisa Holland, Alan G. Jardine, J. Wouter Jukema, John J.P. Kastelein, Sharon Kean, Anthony Keech, Adrienne Kirby, John Kjekshus, Genell L. Knatterud, Robert H. Knopp, Wolfgang Köenig, Michael J. Koren, Vera Krane, Martin Landray, John C. LaRosa, Eva Lonn, Peter W. Macfarlane, Stephen MacMahon, Aldo P. Maggioni, Roberto Marchioli, Ian C. Marschner, Borislava Mihaylova, Lemuel A. Moyé, Sabina A. Murphy, Haruo Nakamura, Andrew Neil, Connie B. Newman, Rachel O’Connell, Chris J. Packard, Sarah Parish, Terje Pedersen, Richard Peto, Marc A. Pfeffer, Neil Poulter, David Preiss, Christina Reith, Paul M. Ridker, Michele Robertson, Frank M. Sacks, Naveed Sattar, Roland E. Schmieder, Patrick W. Serruys, Peter Sever, John Shaw, Charles L. Shear, John Simes, Peter Sleight, Enti Spata, Luigi Tavazzi, Jonathan A. Tobert, Gianni Tognoni, Andrew Tonkin, Stella Trompet, George Varigos, Christoph Wanner, Hans Wedel, Harvey D. White, John Wikstrand, Lars Wilhelmsen, Kate Wilson, Robin Young, Salim Yusuf, Faı̈ez Zannad
HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials
Daniel I. Swerdlow, David Preiss, Karoline Kuchenbaecker, Michael V. Holmes, Jorgen Engmann, Tina Shah, Reecha Sofat, Stefan Stender, P. Johnson, Robert A. Scott, Maarten Leusink, Niek Verweij, Stephen J. Sharp, Yiran Guo, Claudia Giambartolomei, Christina Lee Chung, Anne Peasey, Antoinette Amuzu, KaWah Li, Jutta Palmen, Philip Howard, Jackie A. Cooper, Fotios Drenos, Yun R Li, Gordon Lowe, John Gallacher, Marlene Stewart, Ioanna Tzoulaki, Sarah G. Buxbaum, Daphne L. van der A, Nita G. Forouhi, N. Charlotte Onland‐Moret, Yvonne T. van der Schouw, Renate B. Schnabel, Jaroslav A. Hubáček, Růžena Kubínová, Miglė Bacevičienė, Abdonas Tamošiūnas, Andrzej Pająk, Romanvan Topor-Madry, Urszula Stepaniak, Sofia Malyutina, Damiano Baldassarre, Bengt Sennblad, Elena Tremoli, Ulf dé Fairé, Fabrizio Veglia, Ian Ford, J. Wouter Jukema, Rudi G. J. Westendorp, Gert J. de Borst, Pim A. de Jong, Ale Algra, Wilko Spiering, Anke H. Maitland‐van der Zee, Olaf H. Klungel, Anthonius de Boer, Pieter A. Doevendans, Charles B. Eaton, Jennifer G. Robinson, David Duggan, John Kjekshus, John R. Downs, Antonio M. Gotto, Anthony Keech, Roberto Marchioli, Gianni Tognoni, Peter S. Sever, Neil R Poulter, David D. Waters, Terje R. Pedersen, Pierre Amarenco, Haruo Nakamura, John J.V. McMurray, James Lewsey, Daniel I. Chasman, Paul M. Ridker, Aldo P. Maggioni, Luigi Tavazzi, Kausik K. Ray, Sreenivasa Rao Kondapally Seshasai, JoAnn E. Manson, Jackie F. Price, Peter H. Whincup, Richard Morris, Debbie A. Lawlor, George Davey Smith, Yoav Ben‐Shlomo, Pamela J. Schreiner, Myriam Fornage, David S. Siscovick, Mary Cushman, Meena Kumari, Nick J Wareham, W. M. Monique Verschuren, Susan Redline, Sanjay R. Patel, John C. Whittaker, Anders Hamsten, Joseph A. Delaney
Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial
Marc S. Sabatine, Lawrence A. Leiter, Stephen D. Wiviott, Robert P. Giugliano, Prakash Deedwania, Gaetano Maria De Ferrari, Sabina A. Murphy, Julia Kuder, Ioanna Gouni‐Berthold, Basil S. Lewis, Yehuda Handelsman, Armando Lira Pineda, Narimon Honarpour, Anthony Keech, Peter S. Sever, Terje R. Pedersen
Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events
S. Matthijs Boekholdt, G. Kees Hovingh, Samia Mora, Benoît J. Arsenault, Pierre Amarenco, Terje R. Pedersen, John C. LaRosa, David D. Waters, David A. DeMicco, R. John Simes, Anthony Keech, David Colquhoun, G. A. Hitman, D. J. Betteridge, Michael Clearfield, John R. Downs, Helen M. Colhoun, Antonio M. Gotto, Paul M. Ridker, Scott M. Grundy, John J.P. Kastelein